Introducing Path2P, your guide from discovery to patients.

Get expert-designed preclinical programs and global clinical strategies to accelerate your drug development pathway.

We Chart the Course.
You Reach the Summit.

Our Approach

At Path2P, we take a collaborative, strategic approach to drug development—built on deep regulatory expertise and real-world industry experience. From preclinical study design to global clinical strategy, we tailor each plan to your scientific goals, regulatory requirements, and market realities.

Our team of 35+ specialists—including former FDA officials, regulatory strategists, and legal experts—works alongside you to design efficient, fit-for-purpose programs that accelerate your path to patients. Whether you’re navigating U.S., EU, or Asian markets, we help you make confident, informed decisions at every stage.

We don’t just advise—we guide, carry the load, and clear the path forward.

Globally Connected

Headquartered in Delaware, U.S., Path2P leverages strategic partnerships to serve clients around the world. Through our alliances with partners that specialize in clinical trial logistics and CRO—we extend our reach across the U.S., EU, and Asia.

Our Services